← FDA DRUG APPROVALS

FDA ANDA · ANDA040642

METHSCOPOLAMINE BROMIDE

Sponsor: BRECKENRIDGE PHARM

APPLICATION
ANDA040642
TYPE
ANDA
ORIGINAL APPROVAL
2011-12-06
LATEST ACTION
2011-12-06
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

METHSCOPOLAMINE BROMIDEPrescription
METHSCOPOLAMINE BROMIDE 2.5MG · TABLET · ORAL
METHSCOPOLAMINE BROMIDEPrescription
METHSCOPOLAMINE BROMIDE 5MG · TABLET · ORAL

Approval history

2011-12-06OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →